<billStatus>
 <version>
  3.0.0
 </version>
 <bill>
  <number>
   172
  </number>
  <updateDate>
   2023-03-08T19:58:48Z
  </updateDate>
  <updateDateIncludingText>
   2023-03-08T19:58:48Z
  </updateDateIncludingText>
  <originChamber>
   House
  </originChamber>
  <type>
   HR
  </type>
  <introducedDate>
   2021-01-04
  </introducedDate>
  <congress>
   117
  </congress>
  <constitutionalAuthorityStatementText>
   &lt;pre&gt;[Congressional Record Volume 167, Number 2 (Monday, January 4, 2021)][House]From the Congressional Record Online through the Government Publishing Office [&lt;a href="https://www.gpo.gov"&gt;www.gpo.gov&lt;/a&gt;]By Mr. THOMPSON of California:H.R. 172.Congress has the power to enact this legislation pursuantto the following:Article I[Page H55]&lt;/pre&gt;
  </constitutionalAuthorityStatementText>
  <committees>
   <item>
    <systemCode>
     sscm00
    </systemCode>
    <name>
     Commerce, Science, and Transportation Committee
    </name>
    <chamber>
     Senate
    </chamber>
    <type>
     Standing
    </type>
    <activities>
     <item>
      <name>
       Referred to
      </name>
      <date>
       2021-04-15T16:19:30Z
      </date>
     </item>
    </activities>
   </item>
   <item>
    <systemCode>
     hsif00
    </systemCode>
    <name>
     Energy and Commerce Committee
    </name>
    <chamber>
     House
    </chamber>
    <type>
     Standing
    </type>
    <subcommittees>
     <item>
      <systemCode>
       hsif14
      </systemCode>
      <name>
       Health Subcommittee
      </name>
      <activities>
       <item>
        <name>
         Referred to
        </name>
        <date>
         2021-02-03T00:43:43Z
        </date>
       </item>
      </activities>
     </item>
    </subcommittees>
    <activities>
     <item>
      <name>
       Referred to
      </name>
      <date>
       2021-01-04T15:20:20Z
      </date>
     </item>
    </activities>
   </item>
  </committees>
  <relatedBills>
   <item>
    <title>
     United States Anti-Doping Agency Reauthorization Act of 2021
    </title>
    <congress>
     117
    </congress>
    <number>
     585
    </number>
    <type>
     S
    </type>
    <latestAction>
     <actionDate>
      2021-03-03
     </actionDate>
     <text>
      Read twice and referred to the Committee on Commerce, Science, and Transportation.
     </text>
    </latestAction>
    <relationshipDetails>
     <item>
      <type>
       Identical bill
      </type>
      <identifiedBy>
       CRS
      </identifiedBy>
     </item>
    </relationshipDetails>
   </item>
   <item>
    <title>
     Consolidated Appropriations Act, 2022
    </title>
    <congress>
     117
    </congress>
    <number>
     2471
    </number>
    <type>
     HR
    </type>
    <latestAction>
     <actionDate>
      2022-03-15
     </actionDate>
     <text>
      Became Public Law No: 117-103.
     </text>
    </latestAction>
    <relationshipDetails>
     <item>
      <type>
       Related bill
      </type>
      <identifiedBy>
       CRS
      </identifiedBy>
     </item>
    </relationshipDetails>
   </item>
  </relatedBills>
  <actions>
   <item>
    <actionDate>
     2021-04-15
    </actionDate>
    <committees>
     <item>
      <systemCode>
       sscm00
      </systemCode>
      <name>
       Commerce, Science, and Transportation Committee
      </name>
     </item>
    </committees>
    <sourceSystem>
     <name>
      Senate
     </name>
    </sourceSystem>
    <text>
     Received in the Senate and Read twice and referred to the Committee on Commerce, Science, and Transportation.
    </text>
    <type>
     IntroReferral
    </type>
   </item>
   <item>
    <actionDate>
     2021-04-14
    </actionDate>
    <actionTime>
     16:43:47
    </actionTime>
    <text>
     Motion to reconsider laid on the table Agreed to without objection.
    </text>
    <type>
     Floor
    </type>
    <actionCode>
     H38310
    </actionCode>
    <sourceSystem>
     <code>
      2
     </code>
     <name>
      House floor actions
     </name>
    </sourceSystem>
   </item>
   <item>
    <actionDate>
     2021-04-14
    </actionDate>
    <actionTime>
     16:43:46
    </actionTime>
    <text>
     On motion to suspend the rules and pass the bill Agreed to by the Yeas and Nays: (2/3 required): 381 - 37 (Roll no. 99). (text: CR H1748)
    </text>
    <type>
     Floor
    </type>
    <actionCode>
     H37300
    </actionCode>
    <sourceSystem>
     <code>
      2
     </code>
     <name>
      House floor actions
     </name>
    </sourceSystem>
    <recordedVotes>
     <recordedVote>
      <rollNumber>
       99
      </rollNumber>
      <url>
       https://clerk.house.gov/evs/2021/roll099.xml
      </url>
      <chamber>
       House
      </chamber>
      <congress>
       117
      </congress>
      <date>
       2021-04-14T20:43:46Z
      </date>
      <sessionNumber>
       1
      </sessionNumber>
     </recordedVote>
    </recordedVotes>
   </item>
   <item>
    <actionDate>
     2021-04-14
    </actionDate>
    <actionTime>
     16:43:46
    </actionTime>
    <text>
     Passed/agreed to in House: On motion to suspend the rules and pass the bill Agreed to by the Yeas and Nays: (2/3 required): 381 - 37 (Roll no. 99).(text: CR H1748)
    </text>
    <type>
     Floor
    </type>
    <actionCode>
     8000
    </actionCode>
    <sourceSystem>
     <code>
      9
     </code>
     <name>
      Library of Congress
     </name>
    </sourceSystem>
    <recordedVotes>
     <recordedVote>
      <rollNumber>
       99
      </rollNumber>
      <url>
       https://clerk.house.gov/evs/2021/roll099.xml
      </url>
      <chamber>
       House
      </chamber>
      <congress>
       117
      </congress>
      <date>
       2021-04-14T20:43:46Z
      </date>
      <sessionNumber>
       1
      </sessionNumber>
     </recordedVote>
    </recordedVotes>
   </item>
   <item>
    <actionDate>
     2021-04-14
    </actionDate>
    <actionTime>
     16:06:20
    </actionTime>
    <text>
     Considered as unfinished business. (consideration: CR H1781-1782)
    </text>
    <type>
     Floor
    </type>
    <actionCode>
     H30000
    </actionCode>
    <sourceSystem>
     <code>
      2
     </code>
     <name>
      House floor actions
     </name>
    </sourceSystem>
   </item>
   <item>
    <actionDate>
     2021-04-14
    </actionDate>
    <actionTime>
     12:37:48
    </actionTime>
    <text>
     At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.
    </text>
    <type>
     Floor
    </type>
    <actionCode>
     H37220
    </actionCode>
    <sourceSystem>
     <code>
      2
     </code>
     <name>
      House floor actions
     </name>
    </sourceSystem>
   </item>
   <item>
    <actionDate>
     2021-04-14
    </actionDate>
    <actionTime>
     12:29:18
    </actionTime>
    <text>
     DEBATE - The House proceeded with forty minutes of debate on H.R. 172.
    </text>
    <type>
     Floor
    </type>
    <actionCode>
     H8D000
    </actionCode>
    <sourceSystem>
     <code>
      2
     </code>
     <name>
      House floor actions
     </name>
    </sourceSystem>
   </item>
   <item>
    <actionDate>
     2021-04-14
    </actionDate>
    <actionTime>
     12:29:16
    </actionTime>
    <text>
     Considered under suspension of the rules. (consideration: CR H1748-1750)
    </text>
    <type>
     Floor
    </type>
    <actionCode>
     H30000
    </actionCode>
    <sourceSystem>
     <code>
      2
     </code>
     <name>
      House floor actions
     </name>
    </sourceSystem>
   </item>
   <item>
    <actionDate>
     2021-04-14
    </actionDate>
    <actionTime>
     12:28:57
    </actionTime>
    <text>
     Mr. Pallone moved to suspend the rules and pass the bill.
    </text>
    <type>
     Floor
    </type>
    <actionCode>
     H30300
    </actionCode>
    <sourceSystem>
     <code>
      2
     </code>
     <name>
      House floor actions
     </name>
    </sourceSystem>
   </item>
   <item>
    <actionDate>
     2021-02-02
    </actionDate>
    <committees>
     <item>
      <systemCode>
       hsif14
      </systemCode>
      <name>
       Health Subcommittee
      </name>
     </item>
    </committees>
    <sourceSystem>
     <code>
      1
     </code>
     <name>
      House committee actions
     </name>
    </sourceSystem>
    <text>
     Referred to the Subcommittee on Health.
    </text>
    <type>
     Committee
    </type>
   </item>
   <item>
    <actionDate>
     2021-01-04
    </actionDate>
    <text>
     Referred to the House Committee on Energy and Commerce.
    </text>
    <type>
     IntroReferral
    </type>
    <actionCode>
     H11100
    </actionCode>
    <sourceSystem>
     <code>
      2
     </code>
     <name>
      House floor actions
     </name>
    </sourceSystem>
    <committees>
     <item>
      <systemCode>
       hsif00
      </systemCode>
      <name>
       Energy and Commerce Committee
      </name>
     </item>
    </committees>
   </item>
   <item>
    <actionDate>
     2021-01-04
    </actionDate>
    <text>
     Introduced in House
    </text>
    <type>
     IntroReferral
    </type>
    <actionCode>
     Intro-H
    </actionCode>
    <sourceSystem>
     <code>
      9
     </code>
     <name>
      Library of Congress
     </name>
    </sourceSystem>
   </item>
   <item>
    <actionDate>
     2021-01-04
    </actionDate>
    <text>
     Introduced in House
    </text>
    <type>
     IntroReferral
    </type>
    <actionCode>
     1000
    </actionCode>
    <sourceSystem>
     <code>
      9
     </code>
     <name>
      Library of Congress
     </name>
    </sourceSystem>
   </item>
  </actions>
  <sponsors>
   <item>
    <bioguideId>
     T000460
    </bioguideId>
    <fullName>
     Rep. Thompson, Mike [D-CA-5]
    </fullName>
    <firstName>
     MIKE
    </firstName>
    <lastName>
     THOMPSON
    </lastName>
    <party>
     D
    </party>
    <state>
     CA
    </state>
    <district>
     5
    </district>
    <isByRequest>
     N
    </isByRequest>
   </item>
  </sponsors>
  <cosponsors>
   <item>
    <bioguideId>
     J000292
    </bioguideId>
    <fullName>
     Rep. Johnson, Bill [R-OH-6]
    </fullName>
    <firstName>
     Bill
    </firstName>
    <lastName>
     Johnson
    </lastName>
    <party>
     R
    </party>
    <state>
     OH
    </state>
    <district>
     6
    </district>
    <sponsorshipDate>
     2021-01-04
    </sponsorshipDate>
    <isOriginalCosponsor>
     True
    </isOriginalCosponsor>
   </item>
   <item>
    <bioguideId>
     D000197
    </bioguideId>
    <fullName>
     Rep. DeGette, Diana [D-CO-1]
    </fullName>
    <firstName>
     DIANA
    </firstName>
    <lastName>
     DEGETTE
    </lastName>
    <party>
     D
    </party>
    <state>
     CO
    </state>
    <district>
     1
    </district>
    <sponsorshipDate>
     2021-01-04
    </sponsorshipDate>
    <isOriginalCosponsor>
     True
    </isOriginalCosponsor>
   </item>
  </cosponsors>
  <policyArea>
   <name>
    Sports and Recreation
   </name>
  </policyArea>
  <subjects>
   <legislativeSubjects>
    <item>
     <name>
      Alternative dispute resolution, mediation, arbitration
     </name>
    </item>
    <item>
     <name>
      Athletes
     </name>
    </item>
    <item>
     <name>
      Child health
     </name>
    </item>
    <item>
     <name>
      Congressional oversight
     </name>
    </item>
    <item>
     <name>
      Criminal investigation, prosecution, interrogation
     </name>
    </item>
    <item>
     <name>
      Drug safety, medical device, and laboratory regulation
     </name>
    </item>
    <item>
     <name>
      Drug, alcohol, tobacco use
     </name>
    </item>
    <item>
     <name>
      Due process and equal protection
     </name>
    </item>
    <item>
     <name>
      International law and treaties
     </name>
    </item>
    <item>
     <name>
      International organizations and cooperation
     </name>
    </item>
    <item>
     <name>
      Medical tests and diagnostic methods
     </name>
    </item>
    <item>
     <name>
      Olympic games
     </name>
    </item>
   </legislativeSubjects>
   <policyArea>
    <name>
     Sports and Recreation
    </name>
   </policyArea>
  </subjects>
  <summaries>
   <summary>
    <versionCode>
     00
    </versionCode>
    <actionDate>
     2021-01-04
    </actionDate>
    <actionDesc>
     Introduced in House
    </actionDesc>
    <updateDate>
     2021-02-17T20:10:53Z
    </updateDate>
    <text>
     &lt;p&gt;&lt;strong&gt;United States Anti-Doping Agency Reauthorization Act of 2021&lt;/strong&gt;&lt;/p&gt; &lt;p&gt;This bill authorizes appropriations for the U.S. Anti-Doping Agency (USADA) through FY2030.&lt;/p&gt; &lt;p&gt;The bill adds requirements that USADA&lt;/p&gt; &lt;ul&gt; &lt;li&gt;be responsible for certifying in advance any testing conducted by international organizations under the World Anti-Doping Code for international amateur athletes and athletic competitions occurring within the jurisdiction of the United States; and&lt;/li&gt; &lt;li&gt; promote a positive youth sport experience by using a portion of its funding to provide educational materials on sportsmanship, character building, and healthy performance for those participating in youth sports.&lt;/li&gt; &lt;/ul&gt; &lt;p&gt;The bill requires any action taken by USADA to enforce a policy, procedure, or requirement against a person with respect to a violation of federal law, including an investigation, disciplinary action, sanction, or any other administrative action, to be carried out in a manner that provides due process protection.&lt;/p&gt; &lt;p&gt;The Department of Justice, the Department of Homeland Security, and the Food and Drug Administration&amp;nbsp;must provide to USADA information relating to the prevention of the use of performance-enhancing drugs or the prohibition of performance-enhancing methods.&lt;/p&gt;
    </text>
   </summary>
   <summary>
    <versionCode>
     53
    </versionCode>
    <actionDate>
     2021-04-14
    </actionDate>
    <actionDesc>
     Passed House
    </actionDesc>
    <updateDate>
     2021-04-22T18:17:15Z
    </updateDate>
    <text>
     &lt;p&gt;&lt;strong&gt;United States Anti-Doping Agency Reauthorization Act of 2021&lt;/strong&gt;&lt;/p&gt; &lt;p&gt;This bill authorizes appropriations for the U.S. Anti-Doping Agency (USADA) through FY2030.&lt;/p&gt; &lt;p&gt;The bill adds requirements that USADA&lt;/p&gt; &lt;ul&gt; &lt;li&gt;be responsible for certifying in advance any testing conducted by international organizations under the World Anti-Doping Code for international amateur athletes and athletic competitions occurring within the jurisdiction of the United States; and&lt;/li&gt; &lt;li&gt; promote a positive youth sport experience by using a portion of its funding to provide educational materials on sportsmanship, character building, and healthy performance for those participating in youth sports.&lt;/li&gt; &lt;/ul&gt; &lt;p&gt;The bill requires any action taken by USADA to enforce a policy, procedure, or requirement against a person with respect to a violation of federal law, including an investigation, disciplinary action, sanction, or any other administrative action, to be carried out in a manner that provides due process protection.&lt;/p&gt; &lt;p&gt;The Department of Justice, the Department of Homeland Security, and the Food and Drug Administration&amp;nbsp;must provide to USADA information relating to the prevention of the use of performance-enhancing drugs or the prohibition of performance-enhancing methods.&lt;/p&gt;
    </text>
   </summary>
  </summaries>
  <title>
   United States Anti-Doping Agency Reauthorization Act of 2021
  </title>
  <titles>
   <item>
    <titleType>
     Display Title
    </titleType>
    <title>
     United States Anti-Doping Agency Reauthorization Act of 2021
    </title>
   </item>
   <item>
    <titleType>
     Short Title(s) as Introduced
    </titleType>
    <title>
     United States Anti-Doping Agency Reauthorization Act of 2021
    </title>
    <billTextVersionName>
     Introduced in House
    </billTextVersionName>
    <billTextVersionCode>
     IH
    </billTextVersionCode>
   </item>
   <item>
    <titleType>
     Short Title(s) as Passed House
    </titleType>
    <title>
     United States Anti-Doping Agency Reauthorization Act of 2021
    </title>
    <chamberCode>
     H
    </chamberCode>
    <chamberName>
     House
    </chamberName>
    <billTextVersionName>
     Engrossed in House
    </billTextVersionName>
    <billTextVersionCode>
     EH
    </billTextVersionCode>
   </item>
   <item>
    <titleType>
     Official Title as Introduced
    </titleType>
    <title>
     To reauthorize the United States Anti-Doping Agency, and for other purposes.
    </title>
    <billTextVersionName>
     Engrossed in House
    </billTextVersionName>
    <billTextVersionCode>
     EH
    </billTextVersionCode>
   </item>
   <item>
    <titleType>
     Short Titles as Passed House
    </titleType>
    <title>
     United States Anti-Doping Agency Reauthorization Act of 2021
    </title>
    <chamberCode>
     H
    </chamberCode>
    <chamberName>
     House
    </chamberName>
   </item>
  </titles>
  <textVersions>
   <item>
    <type>
     Referred in Senate
    </type>
    <date>
     2021-04-15T04:00:00Z
    </date>
    <formats>
     <item>
      <url>
       https://www.govinfo.gov/content/pkg/BILLS-117hr172rfs/xml/BILLS-117hr172rfs.xml
      </url>
     </item>
    </formats>
   </item>
   <item>
    <type>
     Engrossed in House
    </type>
    <date>
     2021-04-14T04:00:00Z
    </date>
    <formats>
     <item>
      <url>
       https://www.govinfo.gov/content/pkg/BILLS-117hr172eh/xml/BILLS-117hr172eh.xml
      </url>
     </item>
    </formats>
   </item>
   <item>
    <type>
     Introduced in House
    </type>
    <date>
     2021-01-04T05:00:00Z
    </date>
    <formats>
     <item>
      <url>
       https://www.govinfo.gov/content/pkg/BILLS-117hr172ih/xml/BILLS-117hr172ih.xml
      </url>
     </item>
    </formats>
   </item>
  </textVersions>
  <latestAction>
   <actionDate>
    2021-04-15
   </actionDate>
   <text>
    Received in the Senate and Read twice and referred to the Committee on Commerce, Science, and Transportation.
   </text>
  </latestAction>
 </bill>
 <dublinCore xmlns:dc="http://purl.org/dc/elements/1.1/">
  <dc:format>
   text/xml
  </dc:format>
  <dc:language>
   EN
  </dc:language>
  <dc:rights>
   Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.
  </dc:rights>
  <dc:contributor>
   Congressional Research Service, Library of Congress
  </dc:contributor>
  <dc:description>
   This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.
  </dc:description>
 </dublinCore>
</billStatus>

2021-04-15
Commerce, Science, and Transportation Committee
sscm00
Senate
Received in the Senate and Read twice and referred to the Committee on Commerce, Science, and Transportation.
IntroReferral
H38310
2021-04-14
2
House floor actions
Motion to reconsider laid on the table Agreed to without objection.
Floor
H37300
2021-04-14
2
House floor actions
On motion to suspend the rules and pass the bill Agreed to by the Yeas and Nays: (2/3 required): 381 - 37 (Roll no. 99). (text: CR H1748)
Floor
8000
2021-04-14
9
Library of Congress
Passed/agreed to in House: On motion to suspend the rules and pass the bill Agreed to by the Yeas and Nays: (2/3 required): 381 - 37 (Roll no. 99).(text: CR H1748)
Floor
H30000
2021-04-14
2
House floor actions
Considered as unfinished business. (consideration: CR H1781-1782)
Floor
H37220
2021-04-14
2
House floor actions
At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.
Floor
H8D000
2021-04-14
2
House floor actions
DEBATE - The House proceeded with forty minutes of debate on H.R. 172.
Floor
H30000
2021-04-14
2
House floor actions
Considered under suspension of the rules. (consideration: CR H1748-1750)
Floor
H30300
2021-04-14
2
House floor actions
Mr. Pallone moved to suspend the rules and pass the bill.
Floor
2021-02-02
Health Subcommittee
hsif14
1
House committee actions
Referred to the Subcommittee on Health.
Committee
H11100
2021-01-04
Energy and Commerce Committee
hsif00
2
House floor actions
Referred to the House Committee on Energy and Commerce.
IntroReferral
Intro-H
2021-01-04
9
Library of Congress
Introduced in House
IntroReferral
1000
2021-01-04
9
Library of Congress
Introduced in House
IntroReferral
2021-04-15T16:19:30Z
Referred to
Senate
Commerce, Science, and Transportation Committee
sscm00
Standing
2021-01-04T15:20:20Z
Referred to
House
Energy and Commerce Committee
2021-02-03T00:43:43Z
Referred to
Health Subcommittee
hsif14
hsif00
Standing
J000292
6
Bill
Rep. Johnson, Bill [R-OH-6]
Johnson
R
2021-01-04
OH
D000197
1
DIANA
Rep. DeGette, Diana [D-CO-1]
DEGETTE
D
2021-01-04
CO
Congressional Research Service, Library of Congress
This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.
text/xml
EN
Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.
2021-01-04
2021-04-15
Received in the Senate and Read twice and referred to the Committee on Commerce, Science, and Transportation.
House
Sports and Recreation
2021-03-03
Read twice and referred to the Committee on Commerce, Science, and Transportation.
CRS
Identical bill
United States Anti-Doping Agency Reauthorization Act of 2021
S
2022-03-15
Became Public Law No: 117-103.
CRS
Related bill
Consolidated Appropriations Act, 2022
HR
T000460
5
MIKE
Rep. Thompson, Mike [D-CA-5]
N
THOMPSON
D
CA
Alternative dispute resolution, mediation, arbitration Athletes Child health Congressional oversight Criminal investigation, prosecution, interrogation Drug safety, medical device, and laboratory regulation Drug, alcohol, tobacco use Due process and equal protection International law and treaties International organizations and cooperation Medical tests and diagnostic methods Olympic games
2021-01-04
Introduced in House
 <p><strong>United States Anti-Doping Agency Reauthorization Act of 2021</strong></p> <p>This bill authorizes appropriations for the U.S. Anti-Doping Agency (USADA) through FY2030.</p> <p>The bill adds requirements that USADA</p> <ul> <li>be responsible for certifying in advance any testing conducted by international organizations under the World Anti-Doping Code for international amateur athletes and athletic competitions occurring within the jurisdiction of the United States; and</li> <li> promote a positive youth sport experience by using a portion of its funding to provide educational materials on sportsmanship, character building, and healthy performance for those participating in youth sports.</li> </ul> <p>The bill requires any action taken by USADA to enforce a policy, procedure, or requirement against a person with respect to a violation of federal law, including an investigation, disciplinary action, sanction, or any other administrative action, to be carried out in a manner that provides due process protection.</p> <p>The Department of Justice, the Department of Homeland Security, and the Food and Drug Administration&nbsp;must provide to USADA information relating to the prevention of the use of performance-enhancing drugs or the prohibition of performance-enhancing methods.</p>
2021-02-17T20:10:53Z
00
2021-04-14
Passed House
 <p><strong>United States Anti-Doping Agency Reauthorization Act of 2021</strong></p> <p>This bill authorizes appropriations for the U.S. Anti-Doping Agency (USADA) through FY2030.</p> <p>The bill adds requirements that USADA</p> <ul> <li>be responsible for certifying in advance any testing conducted by international organizations under the World Anti-Doping Code for international amateur athletes and athletic competitions occurring within the jurisdiction of the United States; and</li> <li> promote a positive youth sport experience by using a portion of its funding to provide educational materials on sportsmanship, character building, and healthy performance for those participating in youth sports.</li> </ul> <p>The bill requires any action taken by USADA to enforce a policy, procedure, or requirement against a person with respect to a violation of federal law, including an investigation, disciplinary action, sanction, or any other administrative action, to be carried out in a manner that provides due process protection.</p> <p>The Department of Justice, the Department of Homeland Security, and the Food and Drug Administration&nbsp;must provide to USADA information relating to the prevention of the use of performance-enhancing drugs or the prohibition of performance-enhancing methods.</p>
2021-04-22T18:17:15Z
53
2021-04-15T04:00:00Z
Referred in Senate
https://www.govinfo.gov/content/pkg/BILLS-117hr172rfs/xml/BILLS-117hr172rfs.xml
2021-04-14T04:00:00Z
Engrossed in House
https://www.govinfo.gov/content/pkg/BILLS-117hr172eh/xml/BILLS-117hr172eh.xml
2021-01-04T05:00:00Z
Introduced in House
https://www.govinfo.gov/content/pkg/BILLS-117hr172ih/xml/BILLS-117hr172ih.xml
United States Anti-Doping Agency Reauthorization Act of 2021
United States Anti-Doping Agency Reauthorization Act of 2021
Display Title
IH
Introduced in House
United States Anti-Doping Agency Reauthorization Act of 2021
Short Title(s) as Introduced
EH
Engrossed in House
H
House
United States Anti-Doping Agency Reauthorization Act of 2021
Short Title(s) as Passed House
EH
Engrossed in House
To reauthorize the United States Anti-Doping Agency, and for other purposes.
Official Title as Introduced
H
House
United States Anti-Doping Agency Reauthorization Act of 2021
Short Titles as Passed House
HR
2023-03-08T19:58:48Z
2023-03-08T19:58:48Z
3.0.0
2021-03-03
Read twice and referred to the Committee on Commerce, Science, and Transportation.
CRS
Identical bill
United States Anti-Doping Agency Reauthorization Act of 2021
S
2022-03-15
Became Public Law No: 117-103.
CRS
Related bill
Consolidated Appropriations Act, 2022
HR
2021-04-15
Commerce, Science, and Transportation Committee
sscm00
Senate
Received in the Senate and Read twice and referred to the Committee on Commerce, Science, and Transportation.
IntroReferral
H38310
2021-04-14
2
House floor actions
Motion to reconsider laid on the table Agreed to without objection.
Floor
H37300
2021-04-14
2
House floor actions
On motion to suspend the rules and pass the bill Agreed to by the Yeas and Nays: (2/3 required): 381 - 37 (Roll no. 99). (text: CR H1748)
Floor
8000
2021-04-14
9
Library of Congress
Passed/agreed to in House: On motion to suspend the rules and pass the bill Agreed to by the Yeas and Nays: (2/3 required): 381 - 37 (Roll no. 99).(text: CR H1748)
Floor
H30000
2021-04-14
2
House floor actions
Considered as unfinished business. (consideration: CR H1781-1782)
Floor
H37220
2021-04-14
2
House floor actions
At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.
Floor
H8D000
2021-04-14
2
House floor actions
DEBATE - The House proceeded with forty minutes of debate on H.R. 172.
Floor
H30000
2021-04-14
2
House floor actions
Considered under suspension of the rules. (consideration: CR H1748-1750)
Floor
H30300
2021-04-14
2
House floor actions
Mr. Pallone moved to suspend the rules and pass the bill.
Floor
2021-02-02
Health Subcommittee
hsif14
1
House committee actions
Referred to the Subcommittee on Health.
Committee
H11100
2021-01-04
Energy and Commerce Committee
hsif00
2
House floor actions
Referred to the House Committee on Energy and Commerce.
IntroReferral
Intro-H
2021-01-04
9
Library of Congress
Introduced in House
IntroReferral
1000
2021-01-04
9
Library of Congress
Introduced in House
IntroReferral
T000460
5
MIKE
Rep. Thompson, Mike [D-CA-5]
N
THOMPSON
D
CA
J000292
6
Bill
Rep. Johnson, Bill [R-OH-6]
Johnson
R
2021-01-04
OH
D000197
1
DIANA
Rep. DeGette, Diana [D-CO-1]
DEGETTE
D
2021-01-04
CO
Alternative dispute resolution, mediation, arbitration Athletes Child health Congressional oversight Criminal investigation, prosecution, interrogation Drug safety, medical device, and laboratory regulation Drug, alcohol, tobacco use Due process and equal protection International law and treaties International organizations and cooperation Medical tests and diagnostic methods Olympic games
2021-01-04
Introduced in House
 <p><strong>United States Anti-Doping Agency Reauthorization Act of 2021</strong></p> <p>This bill authorizes appropriations for the U.S. Anti-Doping Agency (USADA) through FY2030.</p> <p>The bill adds requirements that USADA</p> <ul> <li>be responsible for certifying in advance any testing conducted by international organizations under the World Anti-Doping Code for international amateur athletes and athletic competitions occurring within the jurisdiction of the United States; and</li> <li> promote a positive youth sport experience by using a portion of its funding to provide educational materials on sportsmanship, character building, and healthy performance for those participating in youth sports.</li> </ul> <p>The bill requires any action taken by USADA to enforce a policy, procedure, or requirement against a person with respect to a violation of federal law, including an investigation, disciplinary action, sanction, or any other administrative action, to be carried out in a manner that provides due process protection.</p> <p>The Department of Justice, the Department of Homeland Security, and the Food and Drug Administration&nbsp;must provide to USADA information relating to the prevention of the use of performance-enhancing drugs or the prohibition of performance-enhancing methods.</p>
2021-02-17T20:10:53Z
00
2021-04-14
Passed House
 <p><strong>United States Anti-Doping Agency Reauthorization Act of 2021</strong></p> <p>This bill authorizes appropriations for the U.S. Anti-Doping Agency (USADA) through FY2030.</p> <p>The bill adds requirements that USADA</p> <ul> <li>be responsible for certifying in advance any testing conducted by international organizations under the World Anti-Doping Code for international amateur athletes and athletic competitions occurring within the jurisdiction of the United States; and</li> <li> promote a positive youth sport experience by using a portion of its funding to provide educational materials on sportsmanship, character building, and healthy performance for those participating in youth sports.</li> </ul> <p>The bill requires any action taken by USADA to enforce a policy, procedure, or requirement against a person with respect to a violation of federal law, including an investigation, disciplinary action, sanction, or any other administrative action, to be carried out in a manner that provides due process protection.</p> <p>The Department of Justice, the Department of Homeland Security, and the Food and Drug Administration&nbsp;must provide to USADA information relating to the prevention of the use of performance-enhancing drugs or the prohibition of performance-enhancing methods.</p>
2021-04-22T18:17:15Z
53
United States Anti-Doping Agency Reauthorization Act of 2021
United States Anti-Doping Agency Reauthorization Act of 2021
Display Title
IH
Introduced in House
United States Anti-Doping Agency Reauthorization Act of 2021
Short Title(s) as Introduced
EH
Engrossed in House
H
House
United States Anti-Doping Agency Reauthorization Act of 2021
Short Title(s) as Passed House
EH
Engrossed in House
To reauthorize the United States Anti-Doping Agency, and for other purposes.
Official Title as Introduced
H
House
United States Anti-Doping Agency Reauthorization Act of 2021
Short Titles as Passed House
2021-04-15
Received in the Senate and Read twice and referred to the Committee on Commerce, Science, and Transportation.